Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
18/06/26	0.000300 $	0.00%	2,580,000
17/06/26	0.000300 $	-14.29%	2,301,477
16/06/26	0.000350 $	+40.00%	6,804,023
15/06/26	0.000250 $	-16.67%	16,792,526
12/06/26	0.000300 $	0.00%	4,302,708

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Market Closed - OTC Markets Other stock markets 23:43:26 18/06/2026 +04			5-day change	1st Jan Change
0.000300 ^USD	0.00%		0.00%	-40.00%

04-16	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026	CI
02-20	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025	CI

Market Cap	2.35M 2.04M 1.89M 1.77M 3.33M 221M 3.35M 22.47M 8.71M 109M 8.8M 8.61M 378M	P/E 2024	-9.52x	P/E 2025	-11.8x
Enterprise Value	3.35M 2.92M 2.7M 2.53M 4.74M 316M 4.77M 32.05M 12.42M 155M 12.56M 12.29M 540M	EV / Sales 2024	28.9x	EV / Sales 2025	25.6x
Free-Float	41.59%	Yield 2024 *	-	Yield 2025	-

04-16	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026	CI
02-20	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025	CI
23/10/25	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025	CI
06/10/25	Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors	CI
23/09/25	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025	CI
22/09/25	Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
22/04/25	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025	CI
22/01/25	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024	CI
06/01/25	Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products	CI
27/12/24	Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding	CI
27/11/24	Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024	CI
25/11/24	Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip	CI
22/10/24	Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2024	CI

06-15	CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research	NE
06-08	CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers	NE
06-01	CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation	NE
02-20	Cannabis Bioscience International : Quarterly Report for Quarter Ending November 30, 2025 (Form 10-Q)	PU
01-21	CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio	NE

Cannabis Bioscience International Holdings, Inc. Stock

Stocks

CBIH

US16948K1060

Biotechnology & Medical Research

Valuation: Cannabis Bioscience International Holdings, Inc.

Chart: Cannabis Bioscience International Holdings, Inc.

Latest news : Cannabis Bioscience International Holdings, Inc.

Press Releases: Cannabis Bioscience International Holdings, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Cannabis Bioscience International Holdings, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Current month	+50.00%
3 months	-40.00%
6 months	-40.00%
Current year	-40.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.01
10 years	0		0.27

Manager	Title	Age	Since
Dante Picazo CEO	Chief Executive Officer	70	19/12/2019
John Jones TRE	Treasurer	61	06/05/2024
Jose Torres SEC	Corporate Secretary	66	19/12/2019

Director	Title	Age	Since
Dante Picazo BRD	Director/Board Member	70	19/12/2019
Jose Torres BRD	Director/Board Member	66	19/12/2019
John Jones BRD	Director/Board Member	61	06/05/2024

	2024	2025
Net sales	249K 217K 201K 188K 353K 23.48M 355K 2.38M 924K 11.56M 934K 914K 40.13M	303K 264K 245K 229K 430K 28.59M 432K 2.9M 1.13M 14.07M 1.14M 1.11M 48.87M
Net income	-651K -568K -526K -492K -923K -61.46M -929K -6.24M -2.42M -30.25M -2.44M -2.39M -105M	-549K -479K -443K -415K -778K -51.79M -783K -5.26M -2.04M -25.49M -2.06M -2.02M -88.51M
Net Debt	939K 819K 759K 710K 1.33M 88.63M 1.34M 9M 3.49M 43.63M 3.53M 3.45M 151M	1M 872K 808K 756K 1.42M 94.4M 1.43M 9.58M 3.71M 46.46M 3.76M 3.67M 161M

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.	0.00%	0.00%	-50.00%	-40.00%	3.52M
LONZA GROUP AG	+1.44%	+1.71%	-10.63%	-9.16%	43.13B
REVOLUTION MEDICINES, INC.	+3.31%	+5.93%	+308.19%	+562.02%	34.65B
BEONE MEDICINES AG	+2.84%	+2.14%	+6.87%	+34.93%	30.03B
IQVIA HOLDINGS INC.	-1.70%	-7.54%	+8.51%	-22.34%	28B
CELLTRION, INC.	-1.90%	-1.56%	+11.62%	+19.80%	24.45B
ASCENDIS PHARMA A/S	-0.14%	+5.86%	-	-	14.34B
MEDPACE HOLDINGS, INC.	+0.68%	-1.53%	+52.04%	+107.47%	13.14B
EUROFINS SCIENTIFIC SE	-0.57%	-2.43%	+5.18%	+4.20%	12.53B
IONIS PHARMACEUTICALS, INC.	-0.26%	+1.15%	+100.27%	+80.69%	12.25B
Average	+0.37%	+0.66%	+48.01%	+81.96%	21.25B
Weighted average by Cap.	+0.77%	+1.27%	+65.22%	+113.23%